XBP-1s Promotes B Cell Pathogenicity in Chronic GVHD by Restraining the Activity of Regulated IRE-1α-Dependent Decay

Allogeneic hematopoietic cell transplantation (allo-HCT) is an effective therapeutic procedure to treat hematological malignancies. However, the benefit of allo-HCT is limited by a major complication, chronic graft-versus-host disease (cGVHD). Since transmembrane and secretory proteins are generated...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Hee-Jin, Tang, Chih-Hang Anthony, Tian, Linlu, Wu, Yongxia, Sofi, M. Hanief, Ticer, Taylor, Schutt, Steven D., Hu, Chih-Chi Andrew, Yu, Xue-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517405/
https://www.ncbi.nlm.nih.gov/pubmed/34659198
http://dx.doi.org/10.3389/fimmu.2021.705484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517405/
https://www.ncbi.nlm.nih.gov/pubmed/34659198
http://dx.doi.org/10.3389/fimmu.2021.705484

Ejemplares similares